PiSA BioPharm represents the largest Mexican pharmaceutical company-Grupo PiSA. We are the exclusive service provider responsible for managing business development and customer relationships in the US, Canada and Europe for Grupo PiSA. Our goal is to improve & increase the service level to existing customers and expand Value Added Business in the North American and European markets delivering high quality products manufactured at Grupo PiSA's state of the art facilities in Guadalajara. Grupo PiSA is a collaboration of companies providing medical devices, pharmaceutical products, and services to ensure the health of our patients. With more than 16,000 professionals committed to excellence, our companies focus on the development, manufacturing, distribution, and sales of over 1,550 products throughout 14 manufacturing facilities.
View Top Employees from PiSA BioPharm, Inc.Website | http://www.pisa-biopharm.com |
Revenue | $4 million |
Employees | 1,209 (12 on RocketReach) |
Founded | 2014 |
Phone | (518) 417-4887 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Pharmaceuticals, Manufacturing General, Food & Beverages, Manufacturing, Business Development, Contract Manufacturing, Healthcare |
Web Rank | 219277 |
Web Visits | 248070 |
Keywords | Pharmaceutical Products, Pharmaceutical Services, Medical Devices, Healthcare Service, Drug Development And Manufacturing, Biotechnology, Pharmaceutical Manufacturing, Healthcare Solution, Medical Device Manufacturing, Pharmaceutical Distribution |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular PiSA BioPharm, Inc. employee's phone or email?
The PiSA BioPharm, Inc. annual revenue was $4 million in 2024.
Alexina Hess is the Human Resources Business Partner of PiSA BioPharm, Inc..
12 people are employed at PiSA BioPharm, Inc..
PiSA BioPharm, Inc. is based in Guadalajara, Jalisco.
The NAICS codes for PiSA BioPharm, Inc. are [33, 339].
The SIC codes for PiSA BioPharm, Inc. are [38, 384].